Stockholders' Equity

6 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders’ Equity

Stock Repurchase Program. The Company’s Board of Directors has approved various authorizations under the Company’s stock repurchase program to repurchase shares of its common stock in the open market or in privately negotiated transactions (stock repurchase program). As of September 30, 2023, the aggregate remaining approved amount under the stock repurchase program is $1,145,697. The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be suspended at any time at the Company’s discretion.

Stock repurchase activity under the Company’s stock repurchase program was as follows:

	Six Months Ended September 30,
	2023		2022
Dollar value of shares repurchased (1) (2)	$	210,938	$	150,240
Total number of shares repurchased (3)	399,388		557,675
Weighted average price per share paid	$	528.15	$	269.41

(1) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs.

(2) May not calculate on rounded dollars.

(3) All share repurchases were made pursuant to the Company’s stock repurchase program in open-market transactions.

Subsequent to September 30, 2023, through October 12, 2023, the Company repurchased 88,928 shares in open-market transactions for $44,941 at a weighted average price per share paid of $505.36 and had an aggregate authorized amount of $1,100,756 remaining under the stock repurchase program.

Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the condensed consolidated balance sheets are as follows:

	September 30, 2023		March 31, 2023
Unrealized gain on cash flow hedges	$	3,755	$	—
Cumulative foreign currency translation loss	(53,206)		(39,035)
Total	$	(49,451)	$	(39,035)